European Archives - Page 345 of 1100 - European Medical Journal

Lung Cancer: Disparities in Incidence Rates

Incidence rates for lung cancer in US females aged 35-54 were higher than in males and older females, according to research by Ahmedin Jemal, American Cancer Society, Atlanta, Georgia, USA, and colleagues.

Healthcare Inequalities and the Exposome

Michelle Kelly-Irving joins Jonathan to speak about social, economic, and gender inequalities in healthcare, as well as the exposome.

Atypical Hepatitis B-Associated Vasculitis

One of the many extra-hepatic manifestations of hepatitis B virus (HBV) infections is vasculitis. While the classic HBV-associated…

Fibromyalgia: Insights and Perspectives from the Patient and Practitioner

This podcast series explores fibromyalgia from the patient and practitioner perspectives, featuring personal insights and the use of non-pharmacological approaches.

Positive Impact of Prenatal Iron Supplements

Iron supplementation during pregnancy has been shown to successfully reduce maternal anaemia. However, access is not universal. Read more about he direct dispensation of iron supplements during follow-ups

Non-opioid pain medication wins FDA approval

FDA approved a new non-opioid medication for patients with post-operative pain who are being treated in hospital. Read more now.

Investigating the reality of rare disease research

Discover the reality behind the rare disease research with Dr Ian Winburn, Vice President, Global Lead for Rare Hematology, Pfizer

Graft-Versus-Host Disease: Safety of Prophylactic Donor Lymphocyte Infusion

A research team conducted a retrospective study evaluating the efficacy and safety of prophylactic DLI for GVHD prophylaxis after PTCy-based haplo-HCT in paediatric patients with high-risk myeloid neoplasms.

Pharma in Ireland

The Irish pharmaceutical sector is expanding. Read more about what is driving companies to channel investment into the Emerald Isle.

Increased Risk for Oesophageal Cancer After Anti-Reflux Surgery

Despite anti-reflux surgery being recommended for patients with Barrett’s oesophagus in order to decrease the risk of later developing oesophageal adenocarcinoma, recent research suggests that it may be no more effective than anti-reflux medication.